ArticleJournal of medicinal chemistry2022

Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL

Sang Hoon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.